[HTML][HTML] Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

…, FHJ Van den Hoogen, WJ van Venrooij - Arthritis Research & …, 2001 - Springer
The diagnosis of rheumatoid arthritis (RA) is primarily based on clinical symptoms, so it is
often difficult to diagnose RA in very early stages of the disease. A disease-specific …

Mortality in systemic sclerosis: an international meta-analysis of individual patient data

…, F Van Den Hoogen, L Te Boome, JM Van Laar… - The American journal of …, 2005 - Elsevier
PURPOSE: Studies on mortality associated with systemic sclerosis have been limited by
small sample sizes. We aimed to obtain large-scale evidence on survival outcomes and …

[HTML][HTML] Unraveling SSc pathophysiology; the myofibroblast

A van Caam, M Vonk, F van den Hoogen… - Frontiers in …, 2018 - frontiersin.org
Systemic sclerosis (SSc) is a severe auto-immune disease, characterized by vasculopathy
and fibrosis of connective tissues. SSc has a high morbidity and mortality and unfortunately …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

F Van Den Hoogen, D Khanna, J Fransen… - Arthritis & …, 2013 - Wiley Online Library
Frank van den HoogenVan den Hoogen and Pope had full access to all of the data in the
study and take responsibility for the integrity of the data and the accuracy of the data analysis. …

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

…, BAW De Jong, FHJ Van Den Hoogen… - … : Official Journal of …, 2000 - Wiley Online Library
Objective Since modern treatment of rheumatoid arthritis (RA) is shifting toward aggressive
antirheumatic therapy in an early phase of the disease, diagnostic tests with high specificity …

The prognostic value of anti–cyclic citrullinated peptide antibody in patients with recent‐onset rheumatoid arthritis

…, FHJ Van Den Hoogen, M Van't Hof… - … : Official Journal of …, 2000 - Wiley Online Library
The prognostic value of antiâ•ficyclic citrullinated peptide antibody in patients with recentâ•’onset
rheumatoid arthri Page 1 ARTHRITIS & RHEUMATISM Vol. 43, No. 8, August 2000, pp …

Update of EULAR recommendations for the treatment of systemic sclerosis

…, F Van Den Hoogen, JM Van Laar… - Annals of the …, 2017 - ard.bmj.com
The aim was to update the 2009 European League against Rheumatism (EULAR)
recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic …

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial

…, B Griffiths, R Saccardi, FH Van Den Hoogen… - Jama, 2014 - jamanetwork.com
Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …

Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

…, AM Eijsbouts, FHJ van den Hoogen… - Annals of the …, 2009 - ard.bmj.com
Background: Tumour necrosis factor α (TNFα) neutralising antibody constructs are
increasingly being used to treat rheumatoid arthritis (RA). Objective: To determine potential …

Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus

…, MC de Waal Malefijt, FHJ van den Hoogen… - Cell, 1995 - cell.com
Identifying mutations that cause specific osteochondrodysplasias will provide novel insights
into the function of genes that are essential for skeletal morphogenesis. We report here that …